Medtronic Launches Neurovascular Co-Lab Platform to Accelerate Innovation in Stroke Treatment

October 26, 2022—Medtronic announced the launch of the Medtronic Neurovascular Co-Lab Platform, which is designed to accelerate urgently needed innovation in stroke care and treatment. The platform will be launched on October 29, World Stroke Day.

The company stated that the platform will allow innovators, entrepreneurs, and physicians to collaborate, enhance, and share their breakthrough concepts and products.

According to Medtronic, the Neurovascular Co-Lab Platform is an always-on virtual portal for innovator submissions, which are then assessed and prioritized to determine a potential path forward. Chosen opportunities will be advanced based on their individual needs, including exposing innovators to Medtronic’s network of experts, thought leaders and partners for collaboration, clinical study funding, and strategic and directional guidance.

The company is welcoming innovations at every stage of development to move them to the next level; however, high-priority opportunities are high-potential, late-stage clinical and commercial-stage products and technology, followed by physician-led improvements to existing products. More information on the Medtronic Neurovascular Co-Lab Platform is available online at www.medtronic.com/neurovascular-co-lab.

“We need to act now to prioritize the best concepts and strongest products to ensure they reach more patients sooner,” commented Dan Volz in the press release. Volz is president of the Medtronic Neurovascular business, which is part of the Neuroscience Portfolio. “Clinicians and innovators are passionate about improving stroke care, and the neurovascular technology market is brimming with ideas, improvements, and would-be therapies in need of development. Our platform will provide both an infrastructure and a process to realize viable opportunities on a previously unmatched scale.”